Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for decreasing osteoclast formation or bone resorption using an antibody to osteoprotegerin binding protein

Methods for decreasing osteoclast formation or bone resorption using an antibody to osteoprotegerin binding protein

US Patent 7923008 · Granted Apr 12, 2011

Estimated economic value: $249,565,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses there2023
Anti-CD22 antibodies2018
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors2013
Methods for treating bone loss with antibodies to OPGL2013
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors2013
Polynucleotides encoding heavy and light chains of antibodies to OPGL2011
Antibodies to osteoprotegerin binding proteins2010
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors2010
Osteoprotegerin2009
Fhm a novel member of the TNF ligand supergene family: materials and methods for2009
Antibodies to OPGL2008
Osteoprotegerin binding proteins2006